Varro

About:

Varro Life Sciences develops technologies to detect airborne pathogens and prevent disease transmission.

Top Investors: Kanro

Description:

Varro Life Sciences develops and creates improvement on disinfectants to prevent transmission of disease. It provides biotechnological advances to make safe and effective products.

Total Funding Amount:

$20M

Headquarters Location:

New York, New York, United States

Founded Date:

2000-01-01

Contact Email:

info(AT)y2xlifesciences.com

Founders:

David Shuler, Thomas P. Cirrito

Number of Employees:

Last Funding Date:

2024-10-31

IPO Status:

Private

Industries: